Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug-induced hemolytic anemia].

J L Wautier1, P Rouger

  • 1Institut national de la transfusion sanguine, 6, rue Alexandre-Cabanel, 75015 Paris, France. wautier@ints.fr

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|October 20, 2001
PubMed
Summary

Certain drugs can cause hemolytic anemia, a serious side effect. While many drugs are implicated, only about 30 drug classes are confirmed to induce this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012).

Vox sanguinis·2013
Same author

Education in transfusion medicine for medical students and doctors.

Vox sanguinis·2013
Same author

[Red-blood-cell allo-immunization].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2012
Same author

[European Blood Alliance (EBA) and EuroNet TMS: what challenges for the transfusion of tomorrow?].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2011
Same author

International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report.

Vox sanguinis·2011
Same author

Blood group genotyping by high-throughput DNA analysis: application to the French panel of RBC reagents.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2010

Area of Science:

  • Pharmacology
  • Hematology
  • Immunology

Context:

  • Drug administration is a known cause of adverse effects, including hemolytic anemia.
  • Identifying specific drug culprits for drug-induced hemolytic anemia (DIHA) is crucial for patient safety.
  • Autoimmune and immune-mediated hemolysis are significant concerns in clinical practice.

Purpose:

  • To review the established drug classes responsible for inducing hemolytic anemia.
  • To highlight recently identified drugs associated with immune hemolytic anemia.
  • To discuss the association of fludarabine with hemolytic anemia in chronic lymphocytic leukemia and drug-induced hemolytic-uremic syndrome.

Summary:

  • Drug administration can lead to hemolytic anemia, with confirmed links to approximately 30 drug classes.
  • Methyldopa and antibiotics were early identified inducers of autoimmune hemolytic anemia.
  • Diclofenac, cephalosporins, and fludarabine are more recent examples linked to immune hemolytic anemia, while the mechanism for drug-induced hemolytic-uremic syndrome remains unclear.

Impact:

  • Provides a concise overview of drugs known to cause hemolytic anemia.
  • Aids clinicians in recognizing and managing drug-induced hemolytic anemia.
  • Contributes to pharmacovigilance by summarizing established and emerging drug-hemolysis associations.

Related Experiment Videos